Aptus Pharma IPO will open for subscription on September 23, 2025, and close on September 25, 2025. This is a Book Built Issue through which the company plans to raise around ₹13.02 crores, consisting entirely of a fresh issue of ₹13.02 crores along with an offer for sale of equity shares (details not specified) carrying a face value of ₹10 each.

The price band for the IPO is set at ₹65–₹70 per share. The allocation is divided as 50% for QIBs, 15% for HNIs, and 35% for retail investors. The company’s shares are proposed to be listed on the BSE on September 30, 2025, with the allotment expected on September 26, 2025.

In terms of financials, Aptus Pharma recorded revenue of ₹24.64 crores in 2025, up from ₹17.88 crores in 2024. Its profit increased to ₹3.10 crores in 2025 compared to ₹0.80 crores in 2024. Considering these results, investors may view this IPO as a long-term investment opportunity.

About Aptus Pharma IPO

The basic philosophy of our studio is to create individual, aesthetically stunning solutions for our customers by lightning-fast development of projects employing unique styles and architecture. Even if you don’t have a ready sketch of what you want – we will help you to get the result you dreamed of.

The basic philosophy of our studio is to create individual, aesthetically stunning solutions for our customers by lightning-fast development of projects employing unique styles.